SETD4 methylation levels did not differ significantly among other cancer types (Figure 3I); perhaps because there were fewer samples at the M1 stage, a trend of hypomethylation in SETD4 was still discernible in CHOL, MESO, PAAD, TGCT, and UVM. This evidence concerns the gene SETD4 and cancer.